logo
Select company
Select metric
-3446.88%EBIT Margin
VS
Market
3
Sector
12
Industry
21
History
13
$ 26.83Close
$ 15.13 - $ 28.76 52-Week Range
Ticker Information

Ticker

CLDX

Company Name

CELLDEX THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CELLDEX THERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CLDX - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -199.61M-3446.88%$ 5.79M
3/31/2025$ -178.85M-2366.07%$ 7.56M
12/31/2024$ -157.86M-2248.76%$ 7.02M
9/30/2024$ -154.08M-1544.48%$ 9.98M
6/30/2024$ -150.22M-1809.4%$ 8.3M
3/31/2024$ -144.88M-2385.97%$ 6.07M
12/31/2023$ -141.43M-2054.76%$ 6.88M
9/30/2023$ -124.61M-2854.75%$ 4.37M
6/30/2023$ -113.13M-3475.7%$ 3.25M
3/31/2023$ -118.64M-3766.22%$ 3.15M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CELLDEX THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at -1074.46%.
  • Over the past 5 years, CELLDEX THERAPEUTICS INC's average EBIT % has been -3042.23%.
  • The median EBIT % for CELLDEX THERAPEUTICS INC during this period was -2151.76%
  • CELLDEX THERAPEUTICS INC reached its highest EBIT % over the past 5 years at -777.14%.
  • The lowest EBIT % recorded by CELLDEX THERAPEUTICS INC in the same timeframe -12121.48%

CELLDEX THERAPEUTICS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
LENZ : LENZ THERAPEUTICS INC -1037.94%PRAX : PRAXIS PRECISION MEDICINES INC -3232.61%IDYA : IDEAYA BIOSCIENCES INC -4740.03%DNTH : DIANTHUS THERAPEUTICS INC -2364.11%PRME : PRIME MEDICINE INC -4016.83%TSHA : TAYSHA GENE THERAPIES INC -1143.96%PGEN : PRECIGEN INC -2870.25%UPB : UPSTREAM BIO INC -3836.58%VRDN : VIRIDIAN THERAPEUTICS INC -111835.74%JANX : JANUX THERAPEUTICS INC -24064.01%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for CELLDEX THERAPEUTICS INC is calculated as follows: EBIT [ $ -48.55M ] / Revenues [ $ 4.52M ]
(=) EBIT % [ -1074.46% ]

CLDX - EBIT Margin, Last 5 years

-12121.48%

Minimum

Jun 30, 2022

-777.14%

Maximum

Jun 30, 2021

-3042.23%

Average

-2151.76%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.54%
median9.01%
std23.96%